No insider purchase over the last 90 days. The latest, by 원종화, was filed 08 Nov 2024.
Who traded when
BuySaleSince the insiders bought
- +190.0%Entry ₩28,900 · Close at T+365 ₩83,800
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- ●Executives0DART
- ●Executives0DART
- 0KRXDART:20260403003473
- 480,155 sharesKRXDART:20260401004749
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 687,000 sharesKRXDART:20251205000487
- ●Executives0DART
- ●Executives0DART
- 173,533 sharesKRXDART:20250404004101
- ●Executives0DART
- 35,000 sharesShareKRXDART:20250207000891
- 212,166 sharesKRXDART:20250106000322
- 10,679 sharesKRXDART:20250103000564
- 5,614 sharesShareKRXDART:20241108000346Canonical exit: 6 Feb 2025 (T+90)
- 21,000 sharesKRXDART:20241008000559
- 2,316,762 sharesKRXDART:20240905000405
- 8,000 sharesKRXDART:20240830002194
- 4,408,440 sharesKRXDART:20240719000482Canonical exit: 10 Oct 2024 (T+90)
- 0KRXDART:20240705000157
25 of 74 declarations
About ABL Bio Inc.
The record at ABL Bio Inc. (에이비엘바이오) is almost entirely on the selling side: 38 sales against 2 purchases, or 5% purchases, with no recorded amount and so no euro total. Leesanghoon, filed as 대량보유자, made 46 of the 70 filings, 35 sales and no purchase. 원종화 (부사장) made 14, including 1 purchase. The company itself filed 6, a pharmaceutical private equity fund filed 2 (1 purchase, 1 sale) and 국민연금공단 filed 1 sale.
Filings were published from February 15, 2021 to July 16, 2026, from 6 filers, and 30 of them are of another kind. Annual volume has fallen: 18 filings in 2021 and 19 in 2022, then 8 in 2023, 10 in 2024, 8 in 2025 and 7 in 2026. No cluster purchase window stands out.
Read moreShow less
Insiders hold 24.5% of the capital of this health care company, valued at KRW 2.6 trillion. In the last 12 months there are 8 filings, 2 sales and no purchase. On the 22 filings where the delay is known, a typical filing is published 5 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
